Nasdaq First North Premier Growth Market & Implantica

Nasdaq First North Premier Growth Market: Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The FDA approval is likely to positively influence the company's stock performance on this exchange.

Implantica: Implantica received FDA approval for its lead product RefluxStop, enabling U.S. market entry and representing a transformational milestone. This approval is expected to drive substantial commercial growth and positively impact the company's financial performance.

Nasdaq First North Premier Growth Market: Nasdaq First North Premier Growth Market is the listing venue for Implantica, where the company's shares are traded. The event is part of the exchange's regular reporting cycle.

Implantica: Implantica is the company hosting the Q2 2026 earnings presentation. The event provides an opportunity for the company to communicate its financial results and strategic progress to investors.